Nordestgaard BG - Search Results

1

Predicting exacerbations in COPD in the Danish general population.

Marott JL, Ingebrigtsen TS, Çolak Y, Vestbo J, Nordestgaard BG, Lange P. Marott JL, et al. Among authors: nordestgaard bg. Respir Med. 2024 Apr;224:107557. doi: 10.1016/j.rmed.2024.107557. Epub 2024 Feb 13. Respir Med. 2024. PMID: 38355020

2

Cystic fibrosis Delta F508 heterozygotes, smoking, and reproduction: studies of 9141 individuals from a general population sample.

Dahl M, Tybjaerg-Hansen A, Wittrup HH, Lange P, Nordestgaard BG. Dahl M, et al. Among authors: nordestgaard bg. Genomics. 1998 May 15;50(1):89-96. doi: 10.1006/geno.1998.5272. Genomics. 1998. PMID: 9628826

3

DeltaF508 heterozygosity in cystic fibrosis and susceptibility to asthma.

Dahl M, Tybjaerg-Hansen A, Lange P, Nordestgaard BG. Dahl M, et al. Among authors: nordestgaard bg. Lancet. 1998 Jun 27;351(9120):1911-3. doi: 10.1016/s0140-6736(97)11419-2. Lancet. 1998. PMID: 9654257

4

[Carriers of cystic fibrosis are more susceptible to asthma. The Osterbro study].

Dahl M, Hansen AT, Lange P, Nordestgaard BG. Dahl M, et al. Among authors: nordestgaard bg. Ugeskr Laeger. 1999 Aug 9;161(32):4507-9. Ugeskr Laeger. 1999. PMID: 10477965 Danish.

5

Molecular diagnosis of intermediate and severe alpha(1)-antitrypsin deficiency: MZ individuals with chronic obstructive pulmonary disease may have lower lung function than MM individuals.

Dahl M, Nordestgaard BG, Lange P, Vestbo J, Tybjaerg-Hansen A. Dahl M, et al. Among authors: nordestgaard bg. Clin Chem. 2001 Jan;47(1):56-62. Clin Chem. 2001. PMID: 11148177

6

Fifteen-year follow-up of pulmonary function in individuals heterozygous for the cystic fibrosis phenylalanine-508 deletion.

Dahl M, Nordestgaard BG, Lange P, Tybjaerg-Hansen A. Dahl M, et al. Among authors: nordestgaard bg. J Allergy Clin Immunol. 2001 May;107(5):818-23. doi: 10.1067/mai.2001.114117. J Allergy Clin Immunol. 2001. PMID: 11344348

7

Elevated plasma fibrinogen associated with reduced pulmonary function and increased risk of chronic obstructive pulmonary disease.

Dahl M, Tybjaerg-Hansen A, Vestbo J, Lange P, Nordestgaard BG. Dahl M, et al. Among authors: nordestgaard bg. Am J Respir Crit Care Med. 2001 Sep 15;164(6):1008-11. doi: 10.1164/ajrccm.164.6.2010067. Am J Respir Crit Care Med. 2001. PMID: 11587987

8

Change in lung function and morbidity from chronic obstructive pulmonary disease in alpha1-antitrypsin MZ heterozygotes: A longitudinal study of the general population.

Dahl M, Tybjaerg-Hansen A, Lange P, Vestbo J, Nordestgaard BG. Dahl M, et al. Among authors: nordestgaard bg. Ann Intern Med. 2002 Feb 19;136(4):270-9. doi: 10.7326/0003-4819-136-4-200202190-00006. Ann Intern Med. 2002. PMID: 11848724

9

Nose and blood pressure.

Dahl M, Tybjaerg-Hansen A, Nordestgaard BG, Lange P, Vestbo J. Dahl M, et al. Among authors: nordestgaard bg. Am J Respir Crit Care Med. 2004 Jan 15;169(2):318; author reply 319. Am J Respir Crit Care Med. 2004. PMID: 14750217 No abstract available.

10

The protease inhibitor PI*S allele and COPD: a meta-analysis.

Dahl M, Hersh CP, Ly NP, Berkey CS, Silverman EK, Nordestgaard BG. Dahl M, et al. Among authors: nordestgaard bg. Eur Respir J. 2005 Jul;26(1):67-76. doi: 10.1183/09031936.05.00135704. Eur Respir J. 2005. PMID: 15994391 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,128 results

Search Page